Preliminary consolidated sales results of JSC Olainfarm for October 2014 show that the sales of the company were 8.29 million euros, which represents a reduction by 3% compared to the same period one year ago. The biggest sales increases were achieved in Italy and Russia, where they grew by 383% and 55% respectively. During October 2014 significant sales were also made to Germany and Australia. The major sales markets of JSC Olainfarm in October 2014 were Russia, Latvia, Belarus and Ukraine.
| October 2014, consolidated sales | Share in total sales | Changes to October 2013 |
| Russia | 44% | 55% |
| Latvia | 24% | 22% |
| Belarus | 7% | 10% |
| Ukraine | 7% | -62% |
| Italy | 3% | 383% |
| Kazakhstan | 2% | -67% |
| Georgia | 2% | -53% |
| Germany | 2% | NA |
| Australia | 1% | NA |
| Turkmenistan | 1% | 23% |
| Other | 7% | -63% |
| Total | 100% | -3% |
Sales of pharmacy chain of Latvijas aptieka Ltd., fully owned by JSC Olainfarm during October 2014 were 1.48 million euros. 56 pharmacies were operating during this period. Sales of Silvanols Ltd. during October 2014 were 0.4 million euros. Sales were made to 6 European countries.
In ten months of 2014, according to preliminary figures, consolidated sales of JSC Olainfarm were 78.49 million euros, which represents an increase by 25% compared to the same period one year ago. The biggest sales increases during this period were achieved in Poland, where sales increased by 369%, sales to The Netherlands grew by 151%; sales to Ukraine grew by 76%, while sale to Lithuania grew by 45%. The major sales markets of JSC Olainfarm in ten months of 2014 were Russia, Latvia, Ukraine and Belarus.
| 10 months of 2014, consolidated sales | Share in total sales | Changes to 10 months of 2013 |
| Russia | 37% | 19% |
| Latvia | 22% | 21% |
| Ukraine | 14% | 76% |
| Belarus | 8% | 24% |
| Kazakhstan | 2% | -23% |
| The Netherlands | 2% | 151% |
| UK | 2% | -32% |
| Poland | 2% | 369% |
| Uzbekistan | 1% | -12% |
| Lithuania | 1% | 45% |
| Other | 8% | 20% |
| Total | 100% | 25% |
Sales of pharmacy chain of Latvijas aptieka Ltd., fully owned by JSC Olainfarm in ten months of 2014 were 12.5 million euros. Sales of Silvanols Ltd. during this period were 2.78 million euros. Sales were made to 9 European countries.
According to unconsolidated preliminary results of JSC Olainfarm, sales made during October 2104 were 7.21 million euro, which represents a reduction by 7%, compared to the same period one year ago. The biggest sales increases were achieved in Italy and Russia, where they grew by 383% and 55% respectively. During October 2014 significant sales were also made to Germany and Australia. The major sales markets of JSC Olainfarm in October 2014 were Russia, Latvia, Belarus and Ukraine.
| October 2014, unconsolidated sales | Share in total sales | Changes to October 2013 |
| Russia | 51% | 55% |
| Latvia | 14% | 39% |
| Belarus | 8% | 10% |
| Ukraine | 8% | -62% |
| Italy | 3% | 383% |
| Kazakhstan | 2% | -67% |
| Georgia | 2% | -53% |
| Germany | 2% | NA |
| Australia | 2% | NA |
| Turkmenistan | 2% | 23% |
| Other | 6% | -73% |
| Total | 100% | -7% |
In ten months of 2014, according to preliminary figures, unconsolidated sales of JSC Olainfarm were 68.24 million euros, which represents an increase by 26% compared to the same period of 2013. The biggest sales increases during this period were achieved in Poland, where sales increased by 993%, sales to The Netherlands grew by 151%; sales to Ukraine grew by 76%, while sale to Lithuania grew by 51%. According to preliminary unconsolidated sales figured, the major sales markets of JSC Olainfarm in ten months of 2014 were Russia, Ukraine, Latvia and Belarus. In total during nine months the sales have been made to 34 countries on five continents
| 10 months of 2014, unconsolidated sales | Share in total sales | Changes to 10 months of 2013 |
| Russia | 43% | 19% |
| Ukraine | 16% | 76% |
| Latvia | 12% | 34% |
| Belarus | 9% | 24% |
| Kazakhstan | 3% | -23% |
| The Netherlands | 3% | 151% |
| UK | 2% | -32% |
| Poland | 2% | 993% |
| Uzbekistan | 2% | -12% |
| Lithuania | 1% | 51% |
| Other | 9% | 17% |
| Total | 100% | 26% |
On April 29, 2014 an AGM of JSC Olainfarm approved an operating plan of the company, providing that the unconsolidated sales target for 2014 is 80 million euro, while consolidated sales target for 2014 is 93 million euro. According to these preliminary sales results, in ten months of 2014 JSC Olainfarm has met 84% on annual unconsolidated sales target and 84% of annual consolidated sales target.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
